Mettler-Toledo International - MTD STOCK NEWS

Mettler-Toledo International Inc. (NYSE: MTD) reported a 3% increase in sales for the first quarter of 2023. Net earnings per diluted share were $8.47, compared to $7.55 in the prior-year period. Adjusted EPS increased by 10% to $8.69. The company experienced broad-based growth across geographic regions and product categories. Management anticipates local currency sales growth of approximately 3% for the second quarter of 2023 and a growth rate of 5% to 7% for Adjusted EPS.

Mettler-Toledo International (NYSE: MTD) has announced its participation in the BofA Securities 2023 Healthcare Conference, scheduled for May 10, 2023, at 10:40 AM Pacific Time. The company is a leading global supplier of precision instruments and services, holding top market positions across various sectors including life sciences, food, and chemicals. Mettler-Toledo is renowned for its innovation and has established a vast sales and service network, with products sold in over 140 countries. The company's commitment to strong financial performance and growth strategies reinforces its leading status in the industry. For live updates on their presentation, interested parties can visit their investor relations page.

Mettler-Toledo International Inc. (NYSE: MTD) has announced a conference call scheduled for May 5, 2023, at 8:30 a.m. Eastern Time to discuss its quarterly results. The company, a leader in precision instruments and services, claims strong market positions in various sectors, including life sciences, food, and chemicals. Mettler-Toledo operates in over 140 countries with a direct presence in approximately 40, leveraging a comprehensive sales and service network. The firm emphasizes its commitment to innovation and has a proven track record of financial performance through effective growth strategies.

Mettler-Toledo International Inc. (NYSE: MTD) reported fourth-quarter results for 2022, showing a 2% increase in reported sales to $1.058 billion, and a 15% rise in adjusted EPS to $12.10. The Americas region saw sales grow by 8%, while Europe and Asia experienced declines of 3% and 1%, respectively. Full-year EPS rose to $38.41, up from $32.78, with total sales increasing 5% to $3.920 billion. The company anticipates local currency sales growth of 6% for Q1 2023 and forecasts adjusted EPS between $8.55 to $8.65. Management highlights challenges due to currency fluctuations and uncertainties in the economic landscape.

Mettler-Toledo International Inc. (NYSE: MTD) will host a conference call on February 10, 2023, at 8:30 a.m. ET to discuss its quarterly results. Interested parties can access the live webcast at www.mt.com/investors, with a replay available until February 17, 2023. Mettler-Toledo is recognized as a global leader in precision instruments, serving key industries such as life sciences, food, and chemicals. The company’s extensive sales network spans over 140 countries, underpinning its long-term track record of strong financial performance.

Mettler-Toledo International (NYSE:MTD) will present at the 41st Annual JP Morgan Healthcare Conference on January 10, 2023, at 12:00 p.m. ET. Interested investors can access the live webcast on the company’s investor relations page. A replay will be available for seven days. Mettler-Toledo is a global leader in precision instruments, holding strong market positions across various industries, including life sciences and food. The company is recognized for its innovation and extensive sales network, selling products in over 140 countries and having a direct presence in around 40.

Mettler-Toledo International Inc. (NYSE:MTD) announced that Olivier Filliol will not seek re-election to the Board of Directors in May 2023. Filliol, who served as President and CEO from 2008 to 2021 and joined the Board in 2009, played a crucial role in the CEO transition to Patrick Kaltenbach. Board Chair Robert F. Spoerry expressed gratitude for Filliol's invaluable contributions, emphasizing his dedication over 25 years. Mettler-Toledo is recognized as a global leader in precision instruments, with strong market positions and a commitment to innovation in various industries.

Mettler-Toledo International Inc. (NYSE:MTD) will present at the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022, at 11:20 a.m. ET. The presentation will be available via live webcast on the company's investor relations page, with a replay accessible for seven days. Mettler-Toledo is a global leader in precision instruments, serving key industries like life sciences, food, and chemicals. The company holds strong market positions and has a robust sales and service network in over 140 countries, highlighting its commitment to innovation and financial growth.

Mettler-Toledo International (NYSE:MTD) announced the appointment of Ingrid Zhang to its Board of Directors, effective February 1, 2023. Zhang currently serves as President of China, Innovative Medicines at Novartis and has held various leadership roles in multinational pharmaceutical companies. Wah-Hui Chu will retire from the Board in May 2023 due to reaching the mandatory retirement age. Chair Robert F. Spoerry emphasized Zhang's extensive experience in the pharmaceutical industry and strategic insights for the dynamic Chinese market, while thanking Chu for his 16 years of service to the company.